Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Immunological Methods
|
November 7, 2009
A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution
Brian Schlain, Lakshmi Amaravadi, Jean Donley, et al.
Bioanalysis
|
November 7, 2015
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a
Joleen T White, Mary Crossman, Kelly Richter, et al.
Trends in Biotechnology
|
August 10, 2010
Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
Wendy S Putnam, Saileta Prabhu, Yanan Zheng, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 13, 2012
The effect of plasma exchange on serum anti-JC virus antibodies
Meena Subramanyam, Tatiana Plavina, Bhupendra O Khatri, et al.
Journal of Clinical Pharmacology
|
April 12, 2017
Population Pharmacokinetics and Target Engagement of Natalizumab in Patients With Multiple Sclerosis
Kumar Kandadi Muralidharan, Geoffrey Kuesters, Tatiana Plavina, et al.
Nature Biotechnology
|
April 8, 2015
The quintessence of immunogenicity reporting for biotherapeutics
Gopi Shankar, Steven Arkin, Viswanath Devanarayan, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 8, 2013
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee, Tatiana Plavina, Albert Castro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 24, 2014
IV immunoglobulin confounds JC virus antibody serostatus determination
Ilya Kister, Geoffrey Kuesters, Eric Chamot, et al.
Annals of Neurology
|
December 14, 2011
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1
Carmen Bozic, Sandra Richman, Tatiana Plavina, et al.
European Journal of Immunology
|
March 5, 2003
Alefacept selectively promotes NK cell-mediated deletion of CD45R0+ human T cells
Joanne C Cooper, Geoffrey Morgan, Susanne Harding, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Immunological Methods
|
November 7, 2009
A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution
Brian Schlain, Lakshmi Amaravadi, Jean Donley, et al.
Bioanalysis
|
November 7, 2015
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a
Joleen T White, Mary Crossman, Kelly Richter, et al.
Trends in Biotechnology
|
August 10, 2010
Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
Wendy S Putnam, Saileta Prabhu, Yanan Zheng, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 13, 2012
The effect of plasma exchange on serum anti-JC virus antibodies
Meena Subramanyam, Tatiana Plavina, Bhupendra O Khatri, et al.
Journal of Clinical Pharmacology
|
April 12, 2017
Population Pharmacokinetics and Target Engagement of Natalizumab in Patients With Multiple Sclerosis
Kumar Kandadi Muralidharan, Geoffrey Kuesters, Tatiana Plavina, et al.
Nature Biotechnology
|
April 8, 2015
The quintessence of immunogenicity reporting for biotherapeutics
Gopi Shankar, Steven Arkin, Viswanath Devanarayan, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 8, 2013
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee, Tatiana Plavina, Albert Castro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 24, 2014
IV immunoglobulin confounds JC virus antibody serostatus determination
Ilya Kister, Geoffrey Kuesters, Eric Chamot, et al.
Annals of Neurology
|
December 14, 2011
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1
Carmen Bozic, Sandra Richman, Tatiana Plavina, et al.
European Journal of Immunology
|
March 5, 2003
Alefacept selectively promotes NK cell-mediated deletion of CD45R0+ human T cells
Joanne C Cooper, Geoffrey Morgan, Susanne Harding, et al.
Page
of 4